MYR PHARMACEUTICALS

Serial Number 79310875
Registration 6688657
700

Registration Progress

Application Filed
Oct 26, 2020
Under Examination
Approved for Publication
Jan 18, 2022
Published for Opposition
Jan 18, 2022
Registered
Apr 5, 2022

Trademark Image

MYR PHARMACEUTICALS

Basic Information

Serial Number
79310875
Registration Number
6688657
Filing Date
October 26, 2020
Registration Date
April 5, 2022
Published for Opposition
January 18, 2022
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 5, 2022
Registration
Registered
Classes
005 044

Rights Holder

MYR GmbH

16
Address
Burgwedel,
DE

Ownership History

MYR GmbH

Original Applicant
16
DE

MYR GmbH

Owner at Publication
16
DE

MYR GmbH

Original Registrant
16
DE

Legal Representation

Attorney
Gretchen R. Stroud

USPTO Deadlines

Next Deadline
982 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-04-05)
Due Date
April 05, 2028
Grace Period Ends
October 05, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Feb 24, 2023 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Oct 8, 2022 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Sep 26, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 25, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Aug 25, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 5, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 5, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 18, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 18, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 15, 2022 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Dec 29, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 29, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Dec 29, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 15, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 24, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 24, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 24, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 22, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 22, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 22, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 22, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 22, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 6, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 2, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jul 30, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Jun 21, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
May 24, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 24, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 22, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 21, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 20, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 18, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 18, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 13, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of liver, viral, and infectious diseases; pharmaceutical preparations for hepatic diseases or disorders; pharmaceutical preparations for hepatitis D
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Providing information in the medical field
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the wording "MYR PHARMACEUTICALS" in gray next to two quadrilaterals in gray and a triangle in red, with the letters "MYR" in white in the triangle.
Color Claim
The color(s) red, gray, and white is/are claimed as a feature of the mark.

Classification

International Classes
005 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"